AG
ALDR

Advisor Group’s Alder Biopharmaceuticals ALDR Stock Holding History

Advisor Group’s Portfolio ALDR Stock Details ALDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-950
Closed -$18K – 5628
2019
Q3 		$18K Sell
950
-48
-5% -$549 ﹤0.01% 4047
2019
Q2 		$12K Hold
998
– – ﹤0.01% 4298
2019
Q1 		$14K Sell
998
-133
-12% -$1.72K ﹤0.01% 4210
2018
Q4 		$11K Hold
1,131
– – ﹤0.01% 4170
2018
Q3 		$18K Buy
1,131
+133
+13% +$2.4K ﹤0.01% 3967
2018
Q2 		$16K Hold
998
– – ﹤0.01% 3853
2018
Q1 		$14K Sell
998
-118
-11% -$1.71K ﹤0.01% 3905
2017
Q4 		$14K Buy
1,116
+250
+29% +$2.79K ﹤0.01% 3919
2017
Q3 		$11K Buy
866
+4
+0.5% +$42 ﹤0.01% 3941
2017
Q2 		$10K Buy
862
+237
+38% +$4.38K ﹤0.01% 3949
2017
Q1 		$13K Buy
625
+193
+45% +$4.27K ﹤0.01% 3645
2016
Q4 		$9K Buy
432
+250
+137% +$6.5K ﹤0.01% 3694
2016
Q3 		$7K Buy
182
+76
+72% +$2.31K ﹤0.01% 3778
2016
Q2 		$2K Buy
+106
New +$2.87K ﹤0.01% 4152

Advisor Group's ALDR Position: Q4 2019 in Review

Advisor Group sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 950 shares — an estimated $18K sold.

Advisor Group first reported a position in ALDR in Q2 2016 and held it in 14 quarters. The position peaked at $18K in Q3 2019. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.

  • Advisor Group reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • Advisor Group sold 950 Alder Biopharmaceuticals shares in Q4 2019, an estimated $18K.
  • Advisor Group first reported a position in Alder Biopharmaceuticals in Q2 2016 and held it in 14 quarters.
  • Advisor Group's Alder Biopharmaceuticals position peaked at $18K in Q3 2019.
  • 0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.